Trial Profile
A rertrospective, cohort study of apixaban or warfarin in patients with non-valvular atrial fibrillation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Oct 2016
Price :
$35
*
At a glance
- Drugs Apixaban (Primary) ; Warfarin (Primary)
- Indications Stroke
- Focus Adverse reactions; Therapeutic Use
- 06 Oct 2016 New trial record